European Commission Approval Decision Expected Q4 2023
Opinion Based on Positive Results from Global Phase 2 and Ongoing Extension Study
U.S. Food and Drug Administration PDUFA Target Action Date for Supplemental New Drug Application for VOXZOGO for Children Under 5 is Oct. 21, 2023
Read more at prnewswire.com